Evidence supporting the use of: Cannabidiol
For the health condition: Fibromyalgia Syndrome

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Cannabidiol (CBD) has been investigated as a potential adjunct for managing symptoms of Fibromyalgia Syndrome (FMS), primarily due to its purported analgesic and anti-inflammatory properties. The scientific evidence supporting its use is limited but growing. Several small-scale studies and patient surveys suggest that some individuals with fibromyalgia experience reductions in pain and improvements in sleep and quality of life with the use of CBD or cannabis-based products. For example, a 2019 observational study published in Journal of Clinical Rheumatology reported that medical cannabis, including CBD, was associated with pain reduction in fibromyalgia patients. However, most studies combine CBD with THC (tetrahydrocannabinol), making it difficult to isolate the effects of CBD alone.

Systematic reviews, such as one in Current Pain and Headache Reports (2020), conclude that while patient-reported outcomes are promising, there is a lack of large, high-quality randomized controlled trials specifically evaluating pure CBD for fibromyalgia. The mechanism is hypothesized to involve modulation of the endocannabinoid system, which may influence pain perception. Despite anecdotal and preliminary clinical support, current medical guidelines do not formally endorse CBD as a standard treatment for fibromyalgia due to insufficient robust evidence.

In summary, while there is some scientific exploration and low-level evidence for CBD's use in fibromyalgia, the quality and quantity of data remain limited, placing its evidence at a modest level.

More about Cannabidiol
More about Fibromyalgia Syndrome

Products containing Cannabidiol

We currently have no products on Vitabase that contain this ingredient.